Alefounder P R, Baldwin S A, Perham R N, Short N J
Department of Biochemistry, University of Cambridge, U.K.
Biochem J. 1989 Jan 15;257(2):529-34. doi: 10.1042/bj2570529.
Nucleotide sequence analysis of the Escherichia coli chromosomal DNA inserted in the plasmid pLC33-5 of the Clarke and Carbon library [Clarke & Carbon (1976) Cell 9, 91-99] revealed the existence of the gene, fda, encoding the Class II (metal-dependent) fructose 1,6-bisphosphate aldolase of E. coli. The primary structure of the polypeptide chain inferred from the DNA sequence of the fda gene comprises 359 amino acids, including the initiating methionine residue, from which an Mr of 39,146 could be calculated. This value is in good agreement with that of 40,000 estimated from sodium dodecyl sulphate-polyacrylamide gel electrophoresis of the purified dimeric enzyme. The amino acid sequence of the Class II aldolase from E. coli showed no homology with the known amino acid sequences of Class I (imine-forming) fructose 1,6-bisphosphate aldolases from a wide variety of sources. On the other hand, there was obvious homology with the N-terminal sequence of 40 residues already established for the Class II fructose 1,6-bisphosphate aldolase of Saccharomyces cerevisiae. These Class II aldolases, one from a prokaryote and one from a eukaryote, evidently are structurally and evolutionarily related. A 1029 bp-fragment of DNA incorporating the fda gene was excised from plasmid pLC33-5 by digestion with restriction endonuclease HaeIII and subcloned into the expression plasmid pKK223-3, where the gene came under the control of the tac promoter. When grown in the presence of the inducer isopropyl-beta-D-thiogalactopyranoside, E. coli JM101 cells transformed with this recombinant expression plasmid generated the Class II fructose 1,6-bisphosphate aldolase as approx. 70% of their soluble protein. This unusually high expression of an E. coli gene should greatly facilitate purification of the enzyme for any future structural or mechanistic studies.
对插入克拉克和卡本文库的质粒pLC33 - 5中的大肠杆菌染色体DNA进行核苷酸序列分析[克拉克和卡本(1976年),《细胞》9卷,91 - 99页],发现了编码大肠杆菌II类(金属依赖性)1,6 - 二磷酸果糖醛缩酶的fda基因。从fda基因的DNA序列推断出的多肽链一级结构包含359个氨基酸,包括起始甲硫氨酸残基,据此可计算出分子量为39,146。该值与通过纯化的二聚体酶的十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳估计的40,000非常一致。大肠杆菌II类醛缩酶的氨基酸序列与来自多种来源的I类(形成亚胺)1,6 - 二磷酸果糖醛缩酶的已知氨基酸序列没有同源性。另一方面,与已经确定的酿酒酵母II类1,6 - 二磷酸果糖醛缩酶的40个残基的N端序列有明显的同源性。这两种II类醛缩酶,一种来自原核生物,一种来自真核生物,显然在结构和进化上是相关的。通过用限制性内切酶HaeIII消化从质粒pLC33 - 5中切下包含fda基因的1029 bp DNA片段,并亚克隆到表达质粒pKK223 - 3中,该基因置于tac启动子的控制之下。当在诱导剂异丙基 - β - D - 硫代半乳糖苷存在下生长时,用这种重组表达质粒转化的大肠杆菌JM101细胞产生II类1,6 - 二磷酸果糖醛缩酶,其含量约占可溶性蛋白的70%。大肠杆菌基因的这种异常高表达将极大地促进该酶的纯化,以便未来进行任何结构或机制研究。